Methicillin-resistant &lt;em&gt;Staphylococcus aureus&lt;/em&gt; (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review

Maureen U. Okwu; Mitsan Olley; Augustine O. Akpoka; Osazee E. Izevbuwa

doi:10.3934/microbiol.2019.2.117

journal article Jan 01, 2019

Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review

Maureen U. Okwu Mitsan Olley Augustine O. Akpoka Osazee E. Izevbuwa

AIMS Microbiology Vol. 5 No. 2 pp. 117-137 · American Institute of Mathematical Sciences (AIMS)

View at Publisher Save 10.3934/microbiol.2019.2.117

Topics

No keywords indexed for this article. Browse by subject →

References

120

[1]

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

A.-P. Magiorakos, A. Srinivasan, R.B. Carey et al.

Clinical Microbiology and Infection 10.1111/j.1469-0691.2011.03570.x

[2]

2. Basak S, Singh P, Rajurkar M (2016) Multidrug resistant and extensively drug resistant bacteria: A study. J Pathog 2016: 4065603.

[3]

3. Health Research and Educational Trust (HRET). (2017) Multidrug-resistant organisms. Infection change package. Available from: http://www.hret-hiin.org.

[4]

4. Nii-Trebi NI (2017) Emerging and neglected infectious diseases: Insights, advances and challenges. Bio Med Res 2017: 5245021.

[5]

5. Adwan GM, Abu-Shanad BA, Adwan KM (2009) In vitro activity of certain drugs in combination with plant extracts against Staphylococcus aureus infections. Afric J Biotechnol 8: 4239–4241.

[6]

6. World Health Organization (WHO). WHO publishes list of bacteria for which new antibiotics are urgently needed, 2017. Available from: http://who.int/mediacentre/news/releases/2017/bacteria-antibiotics.

[7]

Gardete S, Alexander Tomasz A "Mechanisms of vancomycin resistance in Staphylococcus aureus" J Clin Invest 10.1172/jci68834

[8]

Kali A "Antibiotics and bioactive natural products in treatment of Methicillin-resistant Staphylococcus aureus (MRSA): A brief review" Pharmacogn Rev 10.4103/0973-7847.156329

[9]

Kaur DC, Chate SS "Study of antibiotic resistance pattern in methicillin-resistant Staphylococcus aureus with special reference to newer antibiotic"  J Global Infect Dis 10.4103/0974-777x.157245

[10]

Arunkumar V, Prabagaravarthanan R, Bhaskar M "Prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) infections among patients admitted in critical care units in a tertiary care hospital" Int J Res Med Sci 10.18203/2320-6012.ijrms20172085

[11]

11. McGuinness WA, Malachowa N, DeLeo FR (2017) Vancomycin Resistance in Staphylococcus aureus. Yale J Biol Med 90: 269–281.

[12]

12. Subramani R, Narayanasumy M, Feussner KD (2017) Plant-derived antimicrobials to fight against multidrug-resistant human pathogens. 3 Biotech 7: 172.

[13]

13. Conly JM, Johnston BL (2002) Vancomycin-intermediate Staphylococcus aureus, hetero-vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Staphylococcus aureus: The end of the vancomycin era? Pulsus: The Canadian J Infect Dis 13: 282–284.

[14]

14. Taiwo SS (2011) Antibiotic-resistant bugs in the 21st century: A public health challenge. World J Clin Infect Dis 30: 11–16.

[15]

15. Onemu OS, Ophori EA (2013) Prevalence of multidrug-resistant Staphylococcus aureus in clinical specimens obtained from patients attending the University of Benin Teaching Hospital, Benin City, Nigeria. J Nat Sci Res 3: 154–159.

[16]

Kobayashi SD, Malachowa N, DeLeo FR "Pathogenesis of Staphylococcus aureus abscesses" Am J Pathol 10.1016/j.ajpath.2014.11.030

[17]

Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy

Cin Kong, Hui-min Neoh, Sheila Nathan

Toxins 10.3390/toxins8030072

[18]

Weinstein RA, Fridkin SK "Vancomycin-intermediate and –resistant Staphylococcus aureus: What the infectious disease specialist needs to know" Clin Infect Dis 10.1086/317542

[19]

19. Appelbaum PC (2006) The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect 12: 16–23.

[20]

Loomba PS, Taneja J, Mishra B "Methicillin- and Vancomycin-resistant Staphylococcus aureus in hospitalized patients" J Global Infect Dis 10.4103/0974-777x.68535

[21]

Pinho MG, Filipe SR, De Lencastre H, et al. "Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus" J Bacteriol 10.1128/jb.183.22.6525-6531.2001

[22]

Lee JH "Methicillin (Oxacillin)- resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans" Appl Environ Microbiol 10.1128/aem.69.11.6489-6494.2003

[23]

Harkins CP, Pichon B, Doumith M, et al. "Methicillin-resistant Staphylococcus aureus (MRSA) emerged long before the introduction of methicillin into clinical practice" Genome Biol 10.1186/s13059-017-1252-9

[24]

24. Johnson AP (2011) Methicillin-resistant Staphylococcus aureus (MRSA): The European landscape. J Antimicrob Chemother 66: 43–48.

[25]

25. Okwu M, Bamgbala S, Aborisade W (2012) Prevalence of nasal carriage of Community-associated Methicillin-resistant Staphylococcus aureus among healthy primary school children in Okada, Nigeria. J Nat Sci Res 2: 61–65.

[26]

26. Adhikari R, Pant ND, Neupane S, et al. (2017) Detection of Methicillin-resistant Staphylococcus aureus (MRSA) and determination of Minimum Inhibitory Concentration (MIC) of vancomycin for S. aureus isolated from pus/wound swab samples of the patients attending a tertiary care hospital in Kathmandu, Nepal. Can J Infect Dis Med Microbiol 2017: 2191532.

[27]

27. Rodríguez-Noriega E, Seas C, Guzmán-Blanco M, et al. (2010) Evolution of methicillin-resistant Staphylococcus aureus in Latin America. Int J Infect Dis 14: 7.

[28]

Otto M "Next-generation sequencing to monitor the spread of antimicrobial resistance" Genome Med 10.1186/s13073-017-0461-x

[29]

Sit PS, Teh CS, Idris N, et al. "Prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteremia over a two-year period in a tertiary teaching hospital in Malaysia" BMC Infect Dis 10.1186/s12879-017-2384-y

[30]

Milheiriço C, Oliveira DC, deLencastre H "Update to the multiplex polymerase chain reaction strategy for assignment of mec element types in Staphylococcus aureus" Antimicrob Agents Chemother 10.1128/aac.00275-07

[31]

31. Okwu MU, Mitsan O, Oladeinde B, et al. (2016) Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant staphylococci obtained from clinical samples in south-south, Nigeria. World J Pharm Pharmaceut Sci 5: 91–103.

[32]

32. Amirkhiz MF, Rezaee MA, Hasani A, et al. (2015) Staphylococcal cassette chromosome typing of Methicillin-resistant Staphylococcus aureus (MRSA): An eight year experience. Arch Pediar Infect Dis 3: e30632.

[33]

Rodvold KA, McConeghy KW "Methicillin-resistant Staphylococcus aureus therapy: Past, present and future" Clin Infect Dis 10.1093/cid/cit614

[34]

34. Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing, CLSI approved standard M100-S16, Wayne, PA.

[35]

Tenover FC, Robert C, Moellering RC "The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus" Clin Infect Dis 10.1086/513203

[36]

Howden BP, Davies JK, Paul DR, et al. "Reduced vancomycin susceptibility in Staphylococcus aureus including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection and clinical implications" Clin Microbiol Rev 10.1128/cmr.00042-09

[37]

37. Dhanalashmi TA, Umapathy BL, Mohan DR (2010) Prevalence of methicillin, vancomycin and multidrug resistance among Staphylococcus aureus. J Clin Diagn Res 6: 974–977.

[38]

38. Fridkin SK (2001) Vancomycin-intermediate and resistant Staphylococcus aureus. What infectious disease specialists need to know. Clin Infect Dis 32: 108–115.

[39]

Appelbaum PC "Reduced glycopeptides susceptibility in Methicillin-resistant Staphylococcus aureus (MRSA)" Int J Antimicrob Agents 10.1016/j.ijantimicag.2007.07.011

[40]

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

K Hiramatsu

Journal of Antimicrobial Chemotherapy 10.1093/jac/40.1.135

[41]

Gardete S, Tomasz A "Mechanisms of vancomycin resistance in Staphylococcus aureus" J Clin Invest 10.1172/jci68834

[42]

42. National Committee for Clinical Laboratory Standards (NCCLS) (2007) Performance standards for antimicrobial susceptibility testing; 15th Informational supplement M100-S15, NCCLS Wayne, PA.

[43]

43. National Committee for Clinical Laboratory Standards (NCCLS) (2007) Methods for antimicrobial susceptibility tests for bacteria that grow aerobically; 5th ed. Approved standards, M7-A5, NCCLS Wayne, PA.

[44]

44. Centre for Disease Control and Prevention (CDC) (2002) Staphylococcus aureus resistant to vancomycin- United States. Morb Mortal Weekly Rep (MMWR) 51: 565–567.

[45]

Chang S, Sievert DM, Hageman JC, et al. "Infection with vancomycin-resistant Staphylococcus aureus containing the van A resistance gene" N Engl J Med 10.1056/nejmoa025025

[46]

46. Okwu MU, Okorie TG, Mitsan O, et al. (2014) Prevalence and comparison of three methods for detection of Methicillin-resistant Staphylococcus aureus (MRSA) isolates in tertiary health institutions in Nigeria. Can Open Biol Sci 1: 1–12.

[47]

Ravensbergen SJ, Berends M, Stienstra Y, et al. "High prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) and ESBL among asylum seekers in the Netherlands"  PLoS One 10.1371/journal.pone.0176481

[48]

Stefani S, Chung DR, Lindsay JA, et al. "Methicillin-resistant Staphylococcus aureus (MRSA): Global epidemiology and harmonisation of typing methods" Int J Antimicrob Agents 10.1016/j.ijantimicag.2011.09.030

[49]

49. Vaez H, Tabaraei A, Moradi A, et al. (2011) Evaluation of methicillin resistance Staphylococcus aureus isolated from patients in Golestan province north of Iran. Afri J Microbiol Res 5: 432–436.

[50]

50. Akanbi BO, Mbe JU (2013) Occurrence of methicillin- and vancomycin-resistant Staphylococcus aureus in University of Abuja Teaching Hospital, Abuja, Nigeria. Afri J Clin Exper Microbiol 14: 10–13.

Showing 50 of 120 references

Cited By

117

Occurrence and antimicrobial resistance pattern of E. coli O157:H7 isolated from foods of Bovine origin in Dessie and Kombolcha towns, Ethiopia

Engidaw Abebe, Getachew Gugsa · 2023

PLoS Neglected Tropical Diseases

Whole genome characterization of methicillin-resistant Staphylococcus spp. isolates from aquaculture-cultivated shrimps

Jaykumar Kiritkumar Patel, Ada Zwetlana · 2023

Aquaculture

Metrics

117

Citations

120

References

Details

Published: Jan 01, 2019
Vol/Issue: 5(2)
Pages: 117-137

Authors

Cite This Article

Maureen U. Okwu, Mitsan Olley, Augustine O. Akpoka, et al. (2019). Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review. AIMS Microbiology, 5(2), 117-137. https://doi.org/10.3934/microbiol.2019.2.117

Methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review

You May Also Like

Methicillin-resistant &lt;em&gt;Staphylococcus aureus&lt;/em&gt; (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review

You May Also Like

Methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review